GENEVA, Jan. 4 -- SUNSHINE LAKE PHARMA CO., LTD. (Northern Industrial Area, Songshan LakeDongguan, Guangdong 523000), 广东东阳光药业股份有限公司 (中国广东省东莞市松山湖北部工业园) filed a patent application (PCT/CN2025/103691) for "MYT1 KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF" on Jun 26, 2025. With publication no. WO/2026/002087, the details related to the patent application was published on Jan 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World ...